Matthew Kurian/youtube.com
May 12, 2025, 10:05
Matthew Kurian: ASCO 2025 – A Landmark Year for Breast Cancer Research
Matthew Kurian, Assistant professor of Medicine at the University of Kentucky College of Medicine, shared a post on LinkedIn:
“ASCO 2025: A Landmark Year for Breast Cancer Research
Community oncologists, get ready! The upcoming American Society of Clinical Oncology (ASCO) 2025 Annual Meeting (May 30–June 3, Chicago) is set to showcase groundbreaking breast cancer trials that could reshape clinical practice.
Top 3 Trials to Watch:
ASCENT-04: Innovative first-line therapy for triple-negative breast cancer (TNBC).
DESTINY-09: Advancing HER2-targeted treatments.
SERENA-06: New standards in endocrine therapy.
These studies are poised to offer insights that could directly impact patient care the next day! Look forward to seeing old colleagues and friends! Feel free to reach out if you’d like to meet up!
Don’t Miss Out!
Stay ahead in your practice by engaging with these pivotal studies. For a comprehensive list of breast cancer presentations at ASCO 2025, visit the ASCO Meeting Program Guide.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 12, 2025, 10:06
May 12, 2025, 10:05
May 12, 2025, 09:58
May 12, 2025, 09:52
May 12, 2025, 09:38
May 12, 2025, 09:38
May 12, 2025, 09:37
May 12, 2025, 09:16